1. Clinical pharmacy services in Brazil, particularly cardiometabolic diseases: a systematic scoping review and meta-analyses
- Author
-
Priscila L. Nassur, Marcela Forgerini, Patricia C. Mastroianni, Rosa C. Lucchetta, and Universidade Estadual Paulista (Unesp)
- Subjects
process assessment health care ,Cost-Benefit Analysis ,pharmacists ,lcsh:RS1-441 ,Pharmaceutical Science ,Pharmacy ,Pharmacists ,metabolic diseases ,030226 pharmacology & pharmacy ,mesh:Medication Therapy Management ,mesh:Diabetes Mellitus ,mesh:Quality of Life ,chemistry.chemical_compound ,0302 clinical medicine ,mesh:Brazil ,mesh:Hypertension ,mesh:Reproducibility of Results ,Original Research ,education.field_of_study ,Cost–benefit analysis ,Process Assessment, Health Care ,meta-analysis as topic ,brazil ,Cardiovascular Diseases ,diabetes mellitus ,Hypertension ,mesh:Cardiovascular Diseases ,mesh:Systematic Reviews as Topic ,Brazil ,systematic reviews as topic ,medicine.medical_specialty ,hypertension ,Medication Therapy Management ,Population ,Community Pharmacy Services ,medication therapy management ,lcsh:Pharmacy and materia medica ,mesh:Community Pharmacy Services ,03 medical and health sciences ,pharmaceutical services ,pharmacies ,Metabolic Diseases ,Meta-Analysis as Topic ,Diabetes mellitus ,Medication therapy management ,Diabetes Mellitus ,medicine ,mesh:Pharmacists ,education ,Pharmacies ,business.industry ,cost-benefit analysis ,lcsh:RM1-950 ,mesh:Pharmacies ,Reproducibility of Results ,mesh:Process Assessment, Health Care ,medicine.disease ,community pharmacy services ,cardiovascular diseases ,Clinical pharmacy ,mesh:Pharmaceutical Services ,lcsh:Therapeutics. Pharmacology ,Blood pressure ,mesh:Cost-Benefit Analysis ,mesh:Meta-Analysis as Topic ,quality of life ,chemistry ,Pharmaceutical Services ,Emergency medicine ,Quality of Life ,reproducibility of results ,Glycated hemoglobin ,business ,mesh:Metabolic Diseases ,Systematic Reviews as Topic - Abstract
Made available in DSpace on 2021-06-25T10:44:53Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-01-01 Objective: To map the clinical pharmacy services conducted in Brazil, their characteristics, outcomes, and process measures in general population, as well as the assessment of the clinical impact on people with cardiometabolic diseases (cardiovascular diseases and metabolic diseases). Methods: A systematic scoping review and meta-analysis were conducted. The electronic searches were re-run in March 2020. To the clinical impact assessment, meta-analyses of cardiometabolic outcomes (i.e., change of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total cholesterol, glycated hemoglobin (HbA1c), fasting glycemia, LDL-, and HDL-cholesterol) were led. The risk of bias was assessed with the Cochrane Collaboration tools. Results: 71 studies were identified (7,402 patients), being the majority quasi-experimental studies (n=41) and published by research groups of Southeast Brazil (n=33). Medication therapy management (n=62) was the most frequent clinical pharmacy service, performed on outpatient setting (n=45), with adults or elderly people (n=58) with hypertension (n=18) or diabetes (n=10). Process measures (n=58) (e.g. resolution of drug related-problem) were widely used as indicator, followed by clinical (n=44) (e.g. change in SBP), humanistic (n=12) (e.g. change in quality-of-life score assessed by Short-Form 36 Health Survey Questionnaire), and economic outcomes (n=3) (incremental cost-effectiveness ratio for reduction in HbA1c). Regarding the assessment of clinical impact of the services, 20 studies were included in meta-analyses, showing improvement in most cardiometabolic outcomes when considered individual studies. However, the evidence presents high risk of bias, high heterogeneity (median 67-90%) and imprecision, contributing to wide prediction intervals and low reliability. Conclusions: A predominance of studies on cardiometabolic diseases, process measures, and clinical outcomes were identified. Considering the assessment of the clinical impact of clinical pharmacy services in cardiometabolic diseases, an improvement in most cardiometabolic outcomes was showed, however, with low confidence and wide prediction interval. Therefore, development of larger studies with low risk of bias and major homogeneity is necessary for a better comprehension of clinical pharmacy service characteristics, benefits, and the population groups most benefited. Department of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP) Department of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP)
- Published
- 2020